Whether microvascular invasion (MVI) is a prognosis factor for small hepatocellular carcinoma (sHCC) is controversial, a preoperatively predictive model based on gadoxetate disodium (Gd-EOB-DTPA) MRI is clinical needed for MVI in sHCC.We concluded that alpha-fetoprotein>20 ng/mL, non-smooth margin, incomplete or absent capsule, peritumoral enhancement and larger tumor size were independent risk factors for MVI in patients with sHCC ≤3 cm. Although MVI independently impaired RFS before propensity score matching (PSM), it was ultimately identified as a potential but not an independent risk factor for recurrence in sHCC patients after PSM balancing the confounder — tumor size.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords